Clinical trials
Recruiting Hemoglobinuria, Paroxysmal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 8 |
| 2025 | 7 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Regeneron Pharmaceuticals | 3 |
| Wuhan Createrna Science and Technology Co., Ltd | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Haisco Pharmaceutical Group Co., Ltd. | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| ADARx Pharmaceuticals, Inc. | 1 |
| Apellis Pharmaceuticals, Inc. | 1 |
| Aplastic Anemia and MDS International Foundation | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinuria, Paroxysmal | 30 |
| Anemia, Aplastic | 4 |
| Myelodysplastic Syndromes | 3 |
| Anemia | 2 |
| Anemia, Hemolytic | 2 |
| Hemolysis | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Atypical Hemolytic Uremic Syndrome | 1 |
| Bone Marrow Diseases | 1 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.